1.
The Journal of the Korean Bone and Joint Tumor Society
;
: 99-103, 2012.
Artículo
en Coreano
| WPRIM
| ID: wpr-30022
RESUMEN
Little literature exists about the risk of atypical femoral fracture in patients received zoledronic acid for prevention of skeletal metastasis. We report an atypical subtrochanteric femoral fracture in a patient with multiple myeloma received zoledronic acid. The patient was treated by closed reduction and internal fixation with cephalomedullary nailing.